Atyr Pharma Inc (NASDAQ: ATYR) kicked off on Monday, up 17.02% from the previous trading day, before settling in for the closing price of $0.66. Over the past 52 weeks, ATYR has traded in a range of $0.64-$7.29.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 34.28%. While this was happening, its average annual earnings per share was recorded 5.58%. With a float of $95.56 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.48%, while institutional ownership is 63.42%. The most recent insider transaction that took place on Oct 08 ’25, was worth 612,437. In this transaction Director of this company bought 682,001 shares at a rate of $0.90, taking the stock ownership to the 1,095,024 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director bought 317,999 for $0.94, making the entire transaction worth $299,364. This insider now owns 1,413,023 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.18 earnings per share (EPS), higher than consensus estimate (set at -0.23) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.78% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Take a look at Atyr Pharma Inc’s (ATYR) current performance indicators. Last quarter, stock had a quick ratio of 5.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 401.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
The latest stats from [Atyr Pharma Inc, ATYR] show that its last 5-days average volume of 4.01 million was inferior to 4.91 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 33.65%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 2.07%, which indicates a significant decrease from 70.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0643 in the past 14 days, which was lower than the 0.2733 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8784, while its 200-day Moving Average is $3.4714. Now, the first resistance to watch is $0.8196. This is followed by the second major resistance level at $0.8616. The third major resistance level sits at $0.9443. If the price goes on to break the first support level at $0.6949, it is likely to go to the next support level at $0.6122. Assuming the price breaks the second support level, the third support level stands at $0.5702.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
The company with the Market Capitalisation of 76.19 million has total of 97,987K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -64,020 K annual income. Company’s last quarter sales were recorded 190 K and last quarter income was -25,740 K.
